Literature DB >> 11252895

P63 and P73: P53 mimics, menaces and more.

A Yang1, F McKeon.   

Abstract

Inactivation of the tumour suppressor p53 is the most common defect in cancer cells. The discovery of its two close relatives, p63 and p73, was therefore both provocative and confounding. Were these new genes tumour suppressors, p53 regulators, or evolutionary spin-offs? Both oncogenic and tumour-suppressor properties have now been attributed to the p53 homologues, perhaps reflecting the complex, often contradictory, protein products encoded by these genes. p63 and p73 are further implicated in many p53-independent pathways, including stem-cell regeneration, neurogenesis and sensory processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11252895     DOI: 10.1038/35043127

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  139 in total

1.  The human p73 promoter: characterization and identification of functional E2F binding sites.

Authors:  Ratnam S Seelan; Meredith Irwin; Petra van der Stoop; Chiping Qian; William G Kaelin; Wanguo Liu
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.

Authors:  M Kanovsky; A Raffo; L Drew; R Rosal; T Do; F K Friedman; P Rubinstein; J Visser; R Robinson; P W Brandt-Rauf; J Michl; R L Fine; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

3.  RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability.

Authors:  Jin Zhang; Seong Jun Cho; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

4.  DeltaNp73beta is active in transactivation and growth suppression.

Authors:  Gang Liu; Susan Nozell; Hui Xiao; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

5.  Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.

Authors:  Pamela Ghioni; Fabrizio Bolognese; Pascal H G Duijf; Hans Van Bokhoven; Roberto Mantovani; Luisa Guerrini
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

6.  E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.

Authors:  Urs Hobom; Matthias Dobbelstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  How many mutant p53 molecules are needed to inactivate a tetramer?

Authors:  Wan Mui Chan; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.

Authors:  Pierre-Jacques Hamard; Dana J Lukin; James J Manfredi
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

9.  ROCK-dependent phosphorylation of NUP62 regulates p63 nuclear transport and squamous cell carcinoma proliferation.

Authors:  Masaharu Hazawa; De-Chen Lin; Akiko Kobayashi; Yan-Yi Jiang; Liang Xu; Firli Rahmah Primula Dewi; Mahmoud Shaaban Mohamed; Mitsutoshi Nakada; Makiko Meguro-Horike; Shin-Ichi Horike; H Phillip Koeffler; Richard W Wong
Journal:  EMBO Rep       Date:  2017-12-07       Impact factor: 8.807

10.  PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.

Authors:  Eliana Munarriz; Daniela Barcaroli; Anastasis Stephanou; Paul A Townsend; Carine Maisse; Alessandro Terrinoni; Michael H Neale; Seamus J Martin; David S Latchman; Richard A Knight; Gerry Melino; Vincenzo De Laurenzi
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.